WA Life Sciences Innovation Hub Spotlights Entrepreneur Leighton Read in August
04 July 2024
What’s next for biotech? Join the WA Life Sciences Innovation Hub for an evening of conversation with US-based entrepreneur and venture investor Leighton Read on 20 August, delivered in partnership with RSM and Brandon Capital.
This is a unique opportunity to hear about Leighton’s four decades of experience working in Silicon Valley biotech investing.
Leighton’s impressive career includes roles as Managing Director at Interhealth Partners and Alloy Ventures, and founding key companies such as Affymax NV, Aviron, and Avidia. Currently, he is the Non-Executive Chairman of Global Kinetics and a director at Allay Therapeutics and Glyscend Therapeutics.
Details:
20 August 2024, 5:00 pm-7:30 pm ACST
RSM Australia, Level 32 Exchange Tower (2 The Esplanade, Perth)
Plus networking after the event!